Venlafaxine in neuropathic pain following treatment of breast cancer.
about
Venlafaxine for neuropathic pain in adultsAntidepressants for neuropathic painAntidepressants for neuropathic painAntidepressant Use in Chronic Pain Management: Is There Evidence of a Role for Duloxetine?The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain.Treatment of pain syndromes with venlafaxine.Depression and pain: implications for symptomatic presentation and pharmacological treatments.Antidepressants in the treatment of neuropathic pain.EFNS guidelines on pharmacological treatment of neuropathic pain.Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment.Safety of antidepressants in the elderly.Depression in cancer patients: a critical review.Management of neuropathic pain following treatment for breast cancer in the absence of recurrence: a challenge for the radiation oncologist.Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research.Guidelines for the use of antidepressants in painful rheumatic conditions.The pharmacotherapy of chronic pain: a review.Pharmacotherapy for neuropathic pain.Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre.A review of SSRIs and SNRIs in neuropathic pain.Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature.Coanalgesics for chronic pain therapy: a narrative review.Management of pain in the elderly at the end of life.Management of severe neuropathic cancer pain: an illustrative case and review.Neuropathic pain: strategies in drug discovery and treatment.Cancer treatment-related neuropathic pain syndromes--epidemiology and treatment: an update.Pharmacological options for the management of refractory cancer pain-what is the evidence?Pharmacological Management of Cancer-Related Pain.Systematic review of management of chronic pain after surgery.The Post-mastectomy Pain Syndrome-A Systematic Review of the Treatment Modalities.Serotonin-norepinephrine reuptake inhibitors and the influence of binding affinity (Ki) on analgesia.Treatment of Neuropathic Pain with Venlafaxine: A Systematic Review.[Depression in cancer patients].Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis.Serotonin noradrenaline reuptake inhibitors: New hope for the treatment of chronic pain.Specific effect of levetiracetam in experimental human pain models.The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.Pain in cancer survivors.
P2860
Q24187793-2F609E27-C6B9-4D96-98C1-3371260ABCC3Q24243292-B83E943E-6551-4711-B72C-1275BBE220D5Q24246575-3B8238B2-A85D-40C5-96C2-DF553208425AQ33778992-C186E9BB-1530-481D-9226-F87D97408BF2Q33863747-FF588AF0-C8D3-43BA-A1C1-5A084B6CC49DQ34322978-2F6DE386-9C83-419B-9266-475036AF49ABQ34396586-49E2837C-410D-492A-A391-3042404A8B65Q34420689-8B0AC80C-D5C2-4975-9B6A-7510FF85D4DCQ34573607-D36AAFA7-29A5-459B-B2C9-547229B1E5FBQ34595383-C332C885-8E6F-4083-A2CA-CAB9371678E6Q35194349-0DE079C5-8EE9-4E73-ABC2-D17FCD2F27E2Q35634135-DCB4C6E8-94FF-40D9-AACA-581C331397FFQ35985235-97F03427-0657-4A21-B6DD-AA7A11542CA7Q36127633-E041D76C-7FCC-4837-B874-C5770299AEA8Q36402066-41DE4669-624A-4BA3-B653-C6C123D939E5Q36411163-223F44DE-A9E2-4F88-A0F2-1256B8B6DC4EQ36739954-376B2850-016F-4483-804E-7B3B1B660D35Q37425431-1676A258-4B16-4043-A231-49AB5F8B0646Q37773988-60B26507-7535-4CAF-BA41-B94E4A470B61Q37907386-851398D5-648B-4392-844C-0F6351A7D4FDQ37959164-F354675F-5AC2-4D12-9308-29A9E839A341Q37998511-0AEE8A9D-A38B-422E-8139-3962A8D02409Q38002778-419712FD-C2FD-4FBF-A742-88C8A7EF4F88Q38089846-505337A8-5E65-4823-BD16-D2E616E34F4AQ38252761-A719BC14-B55A-4A0A-B043-5B1D2D1859E3Q38370071-23EECF00-14B9-474A-9B84-5B53038D9FEDQ38672359-6AD380B8-3A18-48F9-B568-09F3948C0011Q38691471-ED62117A-FD0C-489A-92F1-3AE4A516D7BAQ38764535-D3369C5D-F852-4EDF-A89A-6ECA35FC8E84Q38786561-015B5378-20C4-4A57-B195-8A3926D70A14Q39005943-EF8980C0-6A63-4FF3-97C2-BCC4C3DC54C5Q41613902-7B8FE007-F966-4021-8C83-4CEDD8BF209EQ42242223-38BA4267-2F92-41F4-AC0D-2654A13CD83FQ42665607-AB0D9A60-13C3-49B0-9108-FC6F46E43B43Q46537395-F1CF31E9-F36D-4F55-83ED-FE0CA0D80395Q46567091-1DEA9D95-B301-4FDC-BFE4-E3C6AC323CE7Q54960570-64867423-BCEE-4A6F-AC96-F7D4BCAF8DC6
P2860
Venlafaxine in neuropathic pain following treatment of breast cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Venlafaxine in neuropathic pain following treatment of breast cancer.
@en
Venlafaxine in neuropathic pain following treatment of breast cancer.
@nl
type
label
Venlafaxine in neuropathic pain following treatment of breast cancer.
@en
Venlafaxine in neuropathic pain following treatment of breast cancer.
@nl
prefLabel
Venlafaxine in neuropathic pain following treatment of breast cancer.
@en
Venlafaxine in neuropathic pain following treatment of breast cancer.
@nl
P2093
P2860
P356
P1476
Venlafaxine in neuropathic pain following treatment of breast cancer.
@en
P2093
Brita Härtel
Eija Kalso
Tiina Tasmuth
P2860
P356
10.1053/EUJP.2001.0266
P577
2002-01-01T00:00:00Z